ABSTRACT The aim of this work was to investigate the effect of inclusion levels of a 5-bacterial species probiotic in broiler nutrition. Five hundred twenty-five 1-d-old male Cobb broilers were allocated in 5 experimental treatments for 6 wk. The experimental treatments received a corn-soybean coccidiostat-free basal diet and depending on the addition were labeled as follows: no addition (C), 10 8 cfu probiotic/kg of diet (P1), 10 9 cfu probiotic/kg of diet (P2), 10 10 cfu probiotic/kg of diet (P3), and 2.5 mg of avilamycin/kg of diet (A). Each treatment had 3 replicates of 35 broilers each. Treatment effects on broiler growth performance and biomarkers such as ileal and total tract nutrient digestibility, plasma Ig concentration, and cecal microflora composition were determined. Differences among treatments were considered significant when P ≤ 0.05. Overall BW gain was significantly higher in treatment P1 (2,293 g) compared with P2 (2,163 g), C (2,165 g), and P3 (2,167 g), with A (2,230 g) being intermediate and not different from P1. Overall feed conversion ratio values were similar and significantly better for P1 (1.80) and A (1.80) compared with P2 (1.87), C (1.89), and P3 (1.92). Ileal apparent digestibility coefficients (ADC) of CP and ether extract were higher in A. Generally, treatments A and P1 showed an improved total tract ADC for DM, organic matter, ash, ether extract, and AME n values. The total tract ADC of CP was higher in P1, C, and P2. There were no differences between treatments regarding plasma Ig in 14-and 42-d-old broilers. Treatments P2 and P3 were effective at beneficially modulating cecal microflora composition. In particular, the lower cecal coliform concentration (log cfu/g of wet digesta) was seen in P2 (6.12) and P3 (4.90) in 14-and 42-d-old broilers, respectively, whereas at 42 d, P3 and P2 had the highest Bifidobacterium (8.31; 8.08) and Lactobacillus concentrations (8.20; 7.86), respectively. It is concluded that probiotic inclusion level had a significant effect on broiler growth responses, nutrient ADC, AME n , and cecal microflora composition.
INTRODUCTION
So far, the use of antimicrobial growth promoters (AGP) in animal nutrition has been beneficial for the improvement of growth performance and prevention of diseases (Barton, 2000; Snel et al., 2002) . However, contemporary biosecurity threats arising from the increasing resistance of pathogens to antibiotics and the accumulation of antibiotic residues in animal products and the environment (Barton, 2000; Van den Bogaard and Stobberingh, 2000; Snel et al., 2002) elicit a call for a worldwide AGP ban. As a result, in the post-AGP era, it is extremely important for the highly intensive broiler production sector of the poultry industry to achieve performance optimization and minimization of economic losses while ensuring the safety of broiler meat via the control and elimination of foodborne pathogens.
It is becoming increasingly evident that to achieve the aims above and to significantly reduce the use of antibiotics, a combination of intervention strategies such as genetic selection of resistant animals, sanitation practices, elimination of pathogens from feed and water, vaccinations, and applications of suitable feed and water additives (Doyle and Erickson, 2006 ) is required. In this sense, probiotics, classified as zootechnical feed additives (European Commission, 2003) , comprise a functional nutritional approach, whereby maintenance of a healthy gastrointestinal (GI) environment and improved intestinal function is pursued through the intake of adequate quantities of live beneficial microorganisms (Fuller, 1989; FAO/WHO, 2002) .
A growing body of scientific research supports the role of probiotics as effective alternatives to the use of AGP in animal nutrition (Ghadban, 2002; Patterson and Burkholder, 2003) . More recently, beneficial effects of probiotics on broiler i) performance (Kabir et al., 2004; Kralik et al., 2004; Gil De Los Santos et al., 2005; Sun et al., 2005; Mountzouris et al., 2007; Vicente et al., 2007; Apata, 2008) , ii) nutrient digestibility (Apata, 2008; Li et al., 2008) , iii) modulation of intestinal microflora (Koenen et al., 2004; Mountzouris et al., 2007; Teo and Tan, 2007; Yu et al., 2008) , iv) pathogen inhibition (Dalloul et al., 2005; Higgins et al., 2008; Vicente et al., 2008; Mountzouris et al., 2009) , and v) immunomodulation and gut mucosal immunity (Kabir et al., 2004; Koenen et al., 2004; Farnell et al., 2006; Chichlowski et al., 2007; Teo and Tan, 2007) have been reported. However, an unambiguous application of probiotics in broiler nutrition is still far from being possible. This shortfall is not only because of our lack of knowledge on the remarkably complex dynamics of the poultry gut ecosystem (Rehman et al., 2007) but is also due to the multifactor dependence of the efficacy of a probiotic application. For example, probiotic efficacy may depend on factors such as microbial species composition (e.g., single or multistrain) and viability, administration level, application method, frequency of application, overall diet, bird age, overall farm hygiene, and environmental stress factors.
Recently, it was shown that a 5-bacterial species competitive exclusion probiotic product for broilers was effective at promoting broiler growth and at modulating cecal microflora composition and metabolic activity (Mountzouris et al., 2007) . In addition, the same probiotic was effective at reducing Salmonella Enteritidis in Salmonella Enteritidis-challenged broilers (Mountzouris et al., 2009) . The aim of the current research work was to further enhance our knowledge and study the effects of increasing probiotic feed inclusion level in corn-soybean meal (SBM)-based diets on broiler growth performance and other important biomarkers for broiler development and health, such as ileal and total tract nutrient digestibility, humoral immunity at a systemic level, and the composition of cecal microflora at 14, 28, and 42 d of age.
MATERIALS AND METHODS

Birds and Experimental Treatments
Five hundred twenty-five 1-d-old male Cobb broilers were obtained from a local commercial hatchery. Broilers were vaccinated on d 1 for Marek, infectious bronchitis, and Newcastle disease and were randomly allocated in 5 experimental treatments for 6 wk. Each treatment had 105 broilers arranged in 3 replicates of 35 broilers each. Each replicate was assigned to a clean floor pen (2 m 2 ) and birds were raised on a wheat straw shavings litter. Heat was provided with a heating lamp per pen. The temperature was regulated at 27 ± 1°C during the starter phase and at 25 ± 1°C for the rest of the experiment (15 to 42 d). Except from d 1, a 23L:1D lighting program was applied during the experiment. Overall, housing and care of the birds conformed to Faculty of Animal Science and Aquaculture guidelines.
The experimental treatments received a corn-SBM basal diet (BD) and depending on the addition were labeled as follows: BD-no other addition (C), BD containing a probiotic concentration of 10 8 cfu/kg of diet (P1), BD containing a probiotic concentration of 10 9 cfu/kg of diet (P2), BD containing a probiotic concentration of 10 10 cfu/kg of diet (P3), and BD containing avilamycin (MAXUS 100, Elanco Hellas, Agia Paraskevi, Greece) at 2.5 mg/kg of diet (A). The BD was in mash form and was formulated for starter (1 to 14 d), grower (15 to 28 d), and finisher (29 to 42 d) broiler growth periods and its composition is shown in Table  1 . There was no coccidiostat added in the BD. The BD was prepared every 2 wk and stored in sacks in a cool place. Experimental diets and water were available ad libitum.
The probiotic used (PoultryStar ME, Biomin GmbH, Herzogenburg Austria) was a 5-bacterial species product that comprised probiotic bacteria isolated from the crop (Lactobacillus reuteri DSM 16350), jejunum (Enterococcus faecium DSM 16211), ileum (Bifidobacterium animalis DSM 16284), and ceca (Pediococcus acidilactici DSM 16210 and Lactobacillus salivarius DSM 16351) of healthy adult chickens. For each one of the probioticcontaining experimental treatments P1, P2, and P3, the probiotic product was especially formulated so that upon its addition at 1 g/kg of diet, it would give the desirable probiotic concentration in the diet expressed as colony-forming units per kilogram of diet. The probiotic product was added in the BD on a weekly basis. Two feed samples, one upon mixing and the second at the end of each week, were subjected to microbiological analysis to check mixing and product viability in feed.
Broiler Performance Responses
Growth performance parameters such as BW, BW gain, feed intake (FI), and feed conversion ratio (FCR), defined as FI:weight gain (g:g), were determined every 2 wk. Overall BW gain, FI, and FCR were calculated for the whole duration of the experiment.
Bacterial Enumeration in Probiotic Product and Feed
Probiotic product and feed samples were cultured according to Mountzouris et al. (2007) for the enumeration of total anaerobes, lactic acid bacteria, Lactobacillus spp., Bifidobacterium spp., and gram-positive cocci (i.e., Enterococcus and Pediococcus). Results were expressed as log 10 colony-forming units per gram of product or grams in feed. In addition, based on the concentration of probiotic in feed (i.e., total anaerobe count) and the FI data, the intake of probiotic per treatment was calculated and expressed as log 10 colony-forming units per chick per day.
Apparent Ileal and Total Tract Digestibility Coefficients of Nutrients and AME n of Experimental Diets
For the determination of ileal and total tract nutrient digestibility coefficients, chromic oxide was added in each one of the experimental diets, as an analytical marker (Sales and Janssens, 2003) , at a final concentration of 0.5 g of Cr 2 O 3 /kg of diet. On d 21, five broilers per floor pen were removed and placed in battery cages with wire mesh bottom and excreta collection trays. Each cage was equipped with 1 feeding and 2 water troughs placed outside on the front, left, and right sides of the cage, respectively. The digestibility experiment had a 4-d preexperimental adaptation period and 3-d collection period. During the 3-d collection period, excreta from each cage were collected 4 times daily (i.e., with 6-h intervals) and stored in sealed bags at −20°C. Remaining feed in the excreta trays was carefully removed and weighed. Feathers were also removed from the excreta. At the end of the 3-d collection period, all of the birds were killed by severing the jugular vein. The carcasses were subsequently opened and the entire GI tract was exposed carefully. The ileum was ligated and then separated from the rest of the GI tract and subsequently, the ileal content was immediately stored in sealed bags at −20°C.
For the total tract digestibility, excreta collected per cage during the 3-d collection period were pooled and represented 1 replicate (i.e., each treatment had 3 replicates). Similarly, ileal digesta from the 5 birds within a cage were pooled and represented 1 replicate. Feed and excreta samples were subsequently analyzed for DM, organic matter, ash, ether extract (EE), and CP (determined as 6.25 × Kjeldahl nitrogen) using the routine procedures (AOAC, 1984) . Similarly, ileal samples were analyzed for DM, CP, and EE. All analyses were performed in duplicate.
For the determination of total tract apparent protein digestibility, the content of uric acid nitrogen in the excreta was determined according to Marquardt (1983) and was subsequently subtracted from the total excreta nitrogen. Gross dietary and excreta energy was determined by adiabatic bomb calorimetry (Parr Instrument Company, Moline, IL) standardized with benzoic acid. Chromic oxide concentration in the feed and excreta samples was determined after ashing and digestion of samples with phosphoric acid-manganese sulfate and potassium bromate and detection by flame atomic absorption spectrometry according to Williams et al. (1962) .
Apparent ileal and total tract digestibility coefficients of nutrients were calculated relative to the Cr 2 O 3 marker. The AME n values of the experimental diets were calculated relative to the Cr 2 O 3 marker and were corrected to zero nitrogen balance using a factor of 8.22 kcal/g of nitrogen retained according to Hill and Anderson (1958) .
Plasma IgA, IgM, IgG, and Total Ig Concentration
At the age of 14 and 42 d, 8 broilers per treatment were randomly selected and blood samples were collected from the wing vein of the birds in heparinized tubes. Blood samples were subsequently stored in ice, centrifuged at 2,500 × g for 10 min at 4°C, and the plasma was stored at −80°C until antibody analyses.
Plasma IgA, IgM, and IgG concentrations were determined in appropriately diluted samples by a sandwich ELISA using microtiter plates and chicken-specific IgA, IgM, and IgG ELISA quantitation kits (Bethyl Laboratories Inc., Montgomery, TX). The ELISA procedure was carried out according to the protocol of the manufacturer and absorbance was measured at 450 nm. The concentrations of IgA, IgM, and IgG were determined using standard curves constructed from respective Ig standards run on the assay microtiter plate and were expressed as milligrams of IgA, IgM, or IgG per milliliter of plasma. Total plasma Ig concentration was calculated as the sum of the respective plasma IgA, IgM, and IgG concentrations.
Cecal Microflora Composition
Seven broilers per treatment at the age of 14, 28, and 42 d were killed by severing the jugular vein. The carcasses were subsequently opened and the entire GI tract was removed aseptically. The GI tract was then divided into sections (i.e., ileum, ceca, and colon) that were ligated with light twine before separating the ceca from the small intestine. For the bacterial enumeration in cecal digesta per bird, appropriately stored ceca, frozen at −80°C, were thawed and removed from storage bags. Cecal digesta contents were then aseptically emptied in a new sterile bag and were immediately diluted 10-fold (i.e., 10% wt/vol) with sterile ice-cold anoxic PBS (0.1 M; pH 7.0) and subsequently homogenized for 3 min in a stomacher (Bagmixer 100 Minimix, Interscience, Arpents, France). Each cecal digesta homogenate was serially diluted from 10 −1 to 10 −7 . Dilutions were subsequently plated on duplicate selective agar media for enumeration of target bacterial groups.
In particular, total aerobes, coliforms, total anaerobes, Clostridium spp., Lactobacillus spp., Bifidobacterium spp., and gram-positive cocci were enumerated using nutrient agar, MacConkey agar, Wilkins-Chalgren agar, reinforced clostridial agar, Rogosa agar, Beerens agar, and azide agar according to Tuohy et al. (2002) . Plates were then incubated at 39°C for 24 to 72 h aerobically (nutrient and MacConkey agars) or 48 to 120 h anaerobically (Wilkins-Chalgren, clostridial, Beerens, Rogosa, and azide agars) and colonies were counted. Anaerobic incubation was achieved using appropriate catalysts (Anaerocult A, Merck, Darmstadt, Germany) in sealed anaerobic jars (Oxoid, Basingstoke, UK). Results were expressed as log 10 colony-forming units per gram of cecal digesta.
Statistical Analysis
Data on growth performance parameters (BW, BW gain, FI, and FCR), nutrient apparent digestibility coefficients (ADC), and AME n content were based on a pen basis, whereas data on plasma Ig concentrations and cecal bacterial populations were based on individual broilers. Experimental data were analyzed using the GLM-general factorial ANOVA procedure using the SPSS for Windows statistical package program, version 8.0.0 (SPSS Inc., Chicago, IL). The GLM model used in the case of parameters monitored every 2 wk was Y ij = µ + T i + W j + (T × W) ij + e ij , where Y ij = dependent observation; µ = overall mean; T i = effect of treatment (i = 1, 2, 3, 4, 5); W j = effect of growth phase (j = 1, 2, 3); (T × W) ij = effect of interaction between treatment and growth phase; and e ij = the residual error. In the case of parameters determined once such as the overall growth parameters, nutrient ADC, and AME n content, the statistical model included the terms µ, T i , and e ij .
Statistically significant effects were further analyzed and means were compared using Duncan's multiple range test. Statistical significance was determined at P ≤ 0.05.
RESULTS
Broiler Growth Performance
Broiler BW did not differ between the experimental treatments on d 1 (i.e., experimental start) and during the starter growth phase (Table 2) . However, during the grower phase (15 to 28 d), broilers in the low probiotic inclusion level treatment (P1) had higher (P = 0.009) BW (1,338 g) compared with treatments A (1,285 g), P2 (1,275 g), P3 (1,274 g), and C (1,253 g) that were not different between them. Similarly, during the finisher phase (29 to 42 d), treatment P1 (2,343 g) had higher (P = 0.036) BW compared with treatments P2 (2,213 g), C (2,215 g), and P3 (2,217 g) but did not differ from the avilamycin growth promoter treatment A (2,280 g) that was intermediate. There were no significant differences in FI between treatments, during all of the experimental growth phases as well as for the whole experiment (Table 2 ). Significant differences between treatments were noted in FCR during the grower (P = 0.001) and finisher (P = 0.029) growth phases. In both growth phases, treatment P1 had better FCR values compared with treatment C and the other 2 probiotic treatments P2 and P3, whereas treatment A did not differ from P1. As was expected, the growth phase (i.e., time) had a significant effect on growth responses (P = 0.000), irrespective of treatment. Overall BW gain for the whole experiment was higher (P = 0.034) in treatment P1 (2,293 g) compared with treatments P2 (2,163 g), C (2,165 g), and P3 (2,167 g). Treatment A (2,230 g) had intermediate BW gain and was not different from P1. Overall FCR values were similar and better (P = 0.004) for treatments P1 (1.80) and A (1.80) compared with treatments P2 (1.87), C (1.89), and P3 (1.92) that did not differ between them (Table 2) .
There were no significant differences between treatments regarding mortality that was generally low and averaged 3.6% for the whole experiment.
Probiotic Enumeration in Feed Concentration and Daily Probiotic Intake
The concentrations of the probiotic products administered in treatments P1, P2, and P3 were found to be in agreement with the manufacturer. In addition, the mixing and the in-feed viability of the probiotic, assessed on a weekly basis, were according to the experimental specifications (data not shown). As a result of probiotic inclusion levels and the fact that there were no differences in FI, daily probiotic intake per chick was lower (P = 0.000) in P1 compared with P2 and this in turn was lower (P = 0.000) than P3 in each one of the growth phases and for the whole experiment. In particular, during the starter phase, daily probiotic intake for treatments P1, P2, and P3 was calculated to be 6.7, 7.6, and 8.9 log 10 cfu/chick, respectively. For the grower phase, respective values were 7.1, 8.0, and 9.2, whereas values for the finisher phase were 7.2, 8.1, and 9.3 log 10 cfu/chick, respectively. Finally for the whole experiment, the average daily probiotic intake for treatments P1, P2, and P3 was calculated to be 7.0, 7.9, and 9.2 log 10 cfu/chick, respectively.
ADC of Nutrients and AME n of Experimental Diets
The ileal apparent DM digestibility did not differ between treatments. Treatment A had higher (P = 0.030) ileal ADC of CP compared with the other treatments. Similarly, treatment A had higher (P = 0.036) ileal ADC of EE compared with treatments P1, C, and P2, whereas treatment P3 was intermediate and not different from A (Table 3) .
Of the 6 total tract ADC, only nitrogen free extract did not differ significantly between treatments (Table  3) . Generally, treatments A and P1 had comparable and significantly higher ADC values for DM, organic matter, ash, and EE compared with the control treatment C, whereas treatments P2 and P3 had variable ADC values that ranged between treatments A, P1, and C. Interestingly, the total tract ADC of CP in treatments P1, C, and P2 did not differ and were higher (P = 0.050) from P3, with treatment A being intermediate and not different from the rest. The AME n content for treatment C was lower (P = 0.033) compared with treatments P2, P3, and A. Treatment P1 had intermediate AME n content and did not differ from the other 4 treatments (Table 3) . Means with different superscripts within the same row differ significantly (P ≤ 0.05). 1 Data represent means from 3 replicates (i.e., pens) per treatment. 2 C = corn-soybean basal diet (BD); P1 = BD containing 10 8 cfu probiotic/kg; P2 = BD containing 10 9 cfu probiotic/kg; P3 = BD containing 10 10 cfu probiotic/kg; A = BD containing avilamycin at 2.5 mg/kg. Composition of the BD is given in Table 1 . 3 FCR = feed conversion ratio (feed intake:BW gain). 
Plasma Ig
Cecal Microflora Composition
The composition of cecal microflora of broilers at 14, 28, and 42 d of age is shown in Figure 1 . Irrespective of treatment, there was a significant growth phase (i.e., age) effect (P = 0.000) on the microbial populations examined. Although the concentration of coliforms decreased with age, the concentrations of total anaerobes, Clostridium, Bifidobacterium, and gram-positive cocci increased with age, reaching a plateau at 28 d of age. Total aerobes and Lactobacillus reached a maximum concentration at 28 d, which later declined but remained significantly higher than the respective concentrations determined at 14 d.
At the age of 14 d, there were no statistically significant differences among treatments regarding total aerobes, total anaerobes, Clostridium spp., Lactobacillus spp., Bifidobacterium spp., and gram-positive cocci populations (Figure 1) . On the contrary, the concentration (log 10 cfu/g of wet cecal digesta) of coliforms in treatment P2 (6.12) was lower (P = 0.047) compared with A (7.32), whereas treatments C (6.57), P1 (6.72), and P3 (6.87) were intermediate and not different from P1 and A. There were no statistically significant differences for any of the examined microbial populations at 28 d of broiler age (Figure 1) . However, there were significant differences between treatments regarding the populations of coliforms, Lactobacillus, and Bifidobacterium at the age of 42 d. In particular, coliform concentration in the cecal digesta of treatment P3 (4.90) was lower (P = 0.048) compared with treatments A (5.96) and P2 (6.12), whereas treatments C (5.67) and P1 (5.74) were intermediate and not different from the previous 3 treatments. The Lactobacillus concentration was higher (P = 0.000) in treatments P3 (8.20) and P2 (7.86) compared with treatment A (7.36), whereas treatments C (7.63) and P1 (7.57) were intermediate and not significantly different from A and P2. Similarly, treatment P3 (8.31) had the higher (P = 0.044) Bifidobacterium concentration compared with A (7.68) and C (7.45), with treatments P1 (7.69) and P2 (8.08) being intermediate and not significantly different from the treatments above (Figure 1 ).
DISCUSSION
It was speculated that the efficacy of a probiotic to promote broiler growth would be the outcome of a fine tuning of the complex gut ecosystem resulting in improved digestive function, intestinal environment, and broiler health. In this sense, in addition to the growth performance parameters, the determination of nutrient apparent digestibilities, plasma antibody levels, and cecal microflora composition were the main objectives of this study.
Generally, it has been suggested that in animals efficacy for most probiotics could be demonstrated with a daily intake of 10 8 to 10 9 microorganisms (Patterson and Burkholder, 2003) . Indeed, in a previous experiment using the same 5-bacterial strain probiotic product with this work, probiotic efficacy in improving broiler Means with different superscripts within the same row differ significantly (P ≤ 0.05). 1 Data represent means from 3 replicates (i.e., pens) per treatment. 2 C = corn-soybean basal diet (BD); P1 = BD containing 10 8 cfu probiotic/kg; P2 = BD containing 10 9 cfu probiotic/kg; P3 = BD containing 10 10 cfu probiotic/kg; A = BD containing avilamycin at 2.5 mg/kg. Composition of the BD is given in Table 1 . 3 According to the addition of Cr 2 O 3 at 500 mg/kg of diet (i.e., 342.1 mg of Cr/kg of diet), the analyzed levels of Cr (mg/kg of diet) for the diets in treatments C, P1, P2, P3, and A were 351, 335, 353, 361, and 336, respectively.
4 Total tract apparent CP digestibility values have been corrected for uric acid nitrogen in the excreta. Table 1. growth and FCR was demonstrated with a probiotic addition at 10 9 cfu/kg of diet, resulting in an average daily intake of 2 × 10 8 (i.e., log 10 8.4) microorganisms per broiler (Mountzouris et al., 2007) . In this work, the growth-promoting efficacy of the 5-bacterial strain probiotic was reconfirmed. Moreover, the probiotic efficacy was comparable to that of the well-known AGP avilamycin. The inclusion of the avilamycin treatment (A) was considered necessary to check probiotic efficacy as an alternative to the use of AGP in broiler nutrition. However, only a few studies using probiotics in broilers have actually compared their results against an AGP (Sun et al., 2005; Chichlowski et al., 2007; Mountzouris et al., 2007; Teo and Tan, 2007; Li et al., 2008) . The high FCR values seen for all treatments during the starter phase could be due to increased FI in order for the birds to compensate for subrecommended growth temperatures and achieve their growth potential.
Interestingly, the best growth performance was achieved in treatment P1 with the lowest probiotic inclusion level (i.e., 10 8 cfu/kg of diet) compared with treatments P2 and P3. Based on the respective FI data, it was calculated that broilers in treatment P1 had an overall average daily probiotic intake of 10 7 cfu/broiler. In this work, therefore, the best growth performance was achieved with a 10-fold lower probiotic dietary inclusion and actual intake level compared with our previous work (Mountzouris et al., 2007) . A possible explanation for the difference between the 2 studies could be the fact that this study was designed to use coccidiostat-free diets as according to the European Commission (2003); coccidiostats and histomonostats should be phased out by December 31, 2012. A coccidiostat such as salinomycin sodium, used in our previous work (Mountzouris et al., 2007) , is an ionophore that has antibiotic properties (Barton, 2000; Chichlowski et al., 2007) and as a result a higher probiotic concentration might have been necessary to achieve a growthpromoting effect compared with this study.
The fact that treatments P2 and P3 did not promote broiler performance as effectively as P1 and A highlights the importance of evaluating probiotic administration level for maximizing efficacy. Despite the fact that the issue of probiotic application level has also been addressed by other studies using different probiotics (Teo and Tan, 2007; Apata, 2008; Li et al., 2008) , no consistent conclusions could be drawn regarding the effect of increasing probiotic administration level on growth performance. For example, increasing the inclusion level of Bacillus subtilis from 10 4 to 10 6 cfu/kg of diet (Teo and Tan, 2007) improved growth performance compared with the low level or the unsupplemented control. On the other hand, the lower inclusion levels (i.e., 2, 4, and 6 × 10 9 cfu/kg of diet) of Lactobacillus bulgaricus were found to be more effective at improving growth performance compared with the higher level (8 × 10 9 cfu/kg of diet) tested (Apata, 2008) . In another study, when a commercial nondefined probiotic mixture of yeasts and other microbes was administered at levels ranging from 0.2 to 0.6%, no effect on growth performance was found, irrespective of probiotic administration level (Li et al., 2008) . In a study in which inactivated lactic acid bacteria (Lactobacillus acidophilus and Lactobacillus casei) and a fungus (Scytalidium acidophilum) were used, the optimal concentration for administering probiotics was strain-dependent and a higher inclusion level did not always result in better performance (Huang et al., 2004) . Generally, it is very difficult to directly compare different studies using different probiotics and different administration levels because the efficacy of a probiotic application will additionally depend on many other factors stated in the introduction section.
In this study, the improvement in growth performance in treatments P1 and A was concomitant with an improved total tract nutrient digestibility and AME n values determined in 25-to 28-d-old broilers. Treatments P2 and P3 did not show a significant improvement in the total tract digestibility for most of the components determined compared with the negative control (C). Contrary to studies with dietary enzyme supplementation, only a few studies have examined nutrient digestibility in broilers fed probiotics. It was shown that depending on the probiotic inclusion level in the diet, probiotic intake resulted in an improved ADC of nitrogen and fat in broilers fed corn-SBM-based diets at 33 d of age (Apata, 2008) and ileal ADC of energy, DM, calcium, phosphate, CP, and most amino acids in 21-d and 42-d-old broilers (Li et al., 2008) .
In this study, the avilamycin treatment resulted in higher ileal ADC of CP and EE compared with the control and probiotic treatments. An improved nutrient digestibility is concomitant with AGP use because these agents are thought to result in more nutrients becoming available for absorption and animal growth via the suppression of growth and metabolic activities of the gut microflora, as well as alterations in intestinal growth, morphology, and function such as reduction of intestinal epithelium thickness and epithelial cell turnover (Barton, 2000; Miles et al., 2006) . On the other hand, probiotics represent a different concept from AGP, whereby the intake of live microorganisms is aimed to modulate the gut environment and enhance the gut barrier function via the fortification of the beneficial members of the intestinal microflora, the competitive exclusion of pathogens, and the stimulation of the immune system (Koenen et al., 2004; Dalloul et al., 2005; Farnell et al., 2006; Chichlowski et al., 2007; Mountzouris et al., 2007 Mountzouris et al., , 2009 Higgins et al., 2008; Vicente et al., 2008) . Nevertheless, this beneficial protective probiotic function may have a nutrient and energy cost for the host because live microbes have nutrient requirements for their growth and proliferation. This could in turn explain the fact that in this experiment the higher probiotic inclusion level treatments P2 and P3 had generally lower total tract ADC for most of the nutrients examined compared with P1.
The host will also be expected to incur a nutrient cost for the development of an immune response and therefore, in the case of broiler chickens, nutrients will be diverted from growth to immune cell development and function. In this work, we aimed to get a picture of the humoral immune status of broilers via the determination of plasma IgA, IgM, IgG, and total Ig concentrations. These were shown to increase with broiler age, but because there were no differences between treatments, it could be concluded that probiotic inclusion levels had no effect on systemic humoral immune status of the broilers. At first instance, this finding might seem to be in contrast with the results reported by other studies, whereby probiotics resulted in an enhancement of broiler humoral immune response (Huang et al., 2004; Kabir et al., 2004; Koenen et al., 2004) . In the studies above, though, the enhancement of the humoral immune response by probiotics was measured against specific model antigens (Huang et al., 2004; Kabir et al., 2004; Koenen et al., 2004) and could therefore be regarded as an improved capacity of the humoral immune system of birds to cope with foreign antigens. On the other hand, the plasma antibody levels reported in this work provide additional information on the overall broiler humoral immune status at a systemic level and not on the immune response capacity against a specific antigen. In addition, probiotics have been shown to have immunomodulatory activity at a cellular level resulting in an enhanced intestinal cell-mediated mucosal immunity that protected against coccidiosis (Dalloul et al., 2003 (Dalloul et al., , 2005 , an upregulation of heterophil bactericidal mechanisms (Farnell et al., 2006) , and a higher heterophil phagocytic activity in vitro (Teo and Tan, 2007) . Probiotics have also been shown to alter the intestinal mucosal pro-and antiinflammatory cytokine expression (Chichlowski et al., 2007) . However, an in-depth investigation of probiotic effects on broiler cellular and humoral immunity was beyond the scope of this study.
In this work, the potential of the probiotic to fortify beneficial members of the intestinal microflora was evidenced because the probiotic treatments P2 and P3 resulted in a significant elevation of Lactobacillus concentration in the cecal digesta of 42-d-old broilers and in addition, treatment P3 had a significantly increased concentration of Bifidobacterium compared with treatments A and C. A similar potential of the particular probiotic to modulate the composition of cecal microflora has been previously reported (Mountzouris et al., 2007) . However, contrary to our previous work and despite the Enterococcus and Pediococcus components of the probiotic, none of the probiotic treatments significantly increased the concentration of cecal grampositive cocci and this merits further investigation. An inconsistent effect of the probiotic treatments to suppress the levels of coliforms was evidenced in this work. In particular, probiotic treatments P2 at the age of 14 d and P3 in 42-d-old broilers had significantly lower cecal coliform concentrations compared with treatment A by 1.21 and 1.10 log 10 , respectively. Other studies have also demonstrated the potential of probiotics to fortify the intestinal microflora of broiler chickens with beneficial bacteria and suppress potentially pathogenic bacteria (Koenen et al., 2004; Teo and Tan, 2007; Vicente et al., 2008) . In this work, it was also shown that irrespective of experimental treatment, the intestinal bacterial composition changed significantly with age, which is in agreement with literature (Rehman et al., 2007) . In addition, the concentrations of the examined bacteria in the broiler cecal digesta were in range with the respective ones reviewed by Rehman et al. (2007) .
In conclusion, the 5-bacterial strain probiotic was effective at enhancing growth performance and total tract nutrient digestibility when it was included in a corn-SBM-based coccidiostat-free diet at 10 8 cfu/kg. At this inclusion level, the probiotic did not have a significant effect on cecal microflora composition and plasma Ig concentration. It is proposed that optimal probiotic inclusion levels for growth performance in broiler diets should be explicitly examined in context with the feed ingredients and the levels of indispensable amino acids used. A higher inclusion level (e.g., >10
9 cfu/kg) was required for the beneficial modulation of the cecal microflora composition, determined by microbial culture at a genus level. Yet, it cannot be ruled out that modulation could be possible via the fortification of beneficial microbes at species level, even at lower inclusion levels, but this has to be investigated. From a practical point of view, this study highlights the need for a proper adjustment of probiotic inclusion levels in the broiler diet to achieve the desired beneficial outcome.
